Apoptosis Cancer Research Results
Apoptosis, Apoptosis: Click to Expand ⟱
| Source: |
| Type: type of cell death |
Situation in which a cell actively pursues a course toward death upon receiving certain stimuli.
Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die.
|
Melanoma, Melanoma Skin Cancer: Click to Expand ⟱
Melanoma is a rare form of skin cancer. It is more likely to invade nearby tissues and spread to other parts of the body than other types of skin cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
- |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
Melanoma, |
A431 |
|
|
|
RadioS↑, ROS↑, TumCCA↑, Apoptosis↑, ER Stress↑,
| - |
vitro+vivo, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Melanoma, |
A2058 |
|
|
|
- |
in-vitro, |
Melanoma, |
RPMI-7951 |
|
|
|
TumCG↓, Apoptosis↑, PD-L1↓, STAT1↓, tumCV↓, T-Cell↑,
| - |
in-vitro, |
Lung, |
H1299 |
|
|
|
- |
in-vitro, |
Lung, |
H460 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Lung, |
H2030 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
Glycolysis↓, lactateProd↓, PGK1↓, ALDOA↓, GLUT1↓, ENO1↓, ATP↓, Casp9↑, Casp3↑, cl‑PARP↑, PI3K/Akt↓, HK1↓, HK2↓, ROS↑, Apoptosis↑, eff↓, NADPH↓, PPP↓,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
tumCV↓, Apoptosis↑, BAX↑, Cyt‑c↑, Bcl-2↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp9↑, ROS↑, eff↓,
| - |
in-vivo, |
Melanoma, |
B16-F10 |
|
|
|
Dose↝, TumCG↓, TumCP↓, BioAv↓, BioAv↑, other↑, Apoptosis↑, Bax:Bcl2↑, EPR↑, toxicity↝,
| - |
in-vitro, |
Melanoma, |
SK-MEL-28 |
|
|
|
Apoptosis↑, necrosis↑, DNAdam↑, TumCCA↑, ROS↑, Casp3↑, p‑P53↑, ERK↑,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
ROS↑, TumCCA↑, Apoptosis↑, miR-21↓, Bcl-2↓, NF-kB↓, Set9↑,
Apoptosis↑, cl‑Casp3↑, LC3s↑, ER Stress↑, ROS↑, CHOP↑,
TumCG↓, RadioS↑, Apoptosis↑, selectivity↑,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
- |
in-vivo, |
Melanoma, |
NA |
|
|
|
- |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
Apoptosis↑, TumCCA↑, MMP↓, ROS↑, eff↓, NF-kB↓, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP1↑, MDA↑, SOD↓, SOD2↓, GCLM↓, GSTA1↓, FTH1↓, GSTs↓, TumVol↓,
| - |
in-vitro, |
Melanoma, |
A431 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
TumCP↓, Inflam↓, Akt↓, NF-kB↓, COX2↓, GSH↓, ROS↑, MMP↓, TumCCA↑, Apoptosis↑, ChemoSen↑,
| - |
in-vitro, |
Melanoma, |
B16-F10 |
|
|
|
- |
NA, |
NA, |
A375 |
|
|
|
ROS↑, TumCP↓, Apoptosis↑, Necroptosis↑, mtDam↑, DNAdam↑, selectivity↑, Dose↝, MPT↓,
| - |
in-vivo, |
Melanoma, |
B16-BL6 |
|
|
|
eff↑, Ki-67↓, TumCP↓, Apoptosis↑, TumCG↓,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
- |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
TumCP↓, ChemoSen↑, cycD1/CCND1↓, Bcl-2↓, survivin↓, XIAP↓, Mcl-1↓, NF-kB↓, IL6↓, STAT3↓, Apoptosis↑, TumCCA↑, Casp3↑, HSP90↓, HO-1↑, JAK2↓, Src↓, Akt↑,
tumCV↓, selectivity↑, MPT↑, Cyt‑c↑, Casp3↑, Casp9↑, Apoptosis↑, mtDam↑, chemoPv↑,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
Apoptosis↑, ROS↑, GSH↓, MMP↓,
| - |
in-vivo, |
Melanoma, |
B16-F10 |
|
|
|
Apoptosis↑, ICD↑, HMGB1↑, ATP↓, TumCG↓,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
tumCV↓, Apoptosis↑, ROS↑, p66Shc↑,
| - |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
TumCG↓, Apoptosis↑, ROS↑, Casp3↑, cl‑PARP↑, SIRT1↓, eff↓,
| - |
in-vitro, |
Melanoma, |
U251 |
|
|
|
- |
in-vitro, |
Melanoma, |
MM.1S |
|
|
|
STAT3↓, PTEN↑, Apoptosis↑, PTPN6↑,
| - |
in-vitro, |
Lung, |
H157 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Colon, |
HCT15 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
TrxR↓, selectivity↑, eff↑, eff↝, ROS↑, MMP↓, Apoptosis↑, eff↑,
tumCV↓, Apoptosis↑, P53↑, γH2AX↑, Akt↓, ROS↑, DNAdam↑,
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Melanoma, |
A431 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
tumCV↓, GSH↓, MDA↑, ROS↑, Apoptosis↑,
| - |
in-vivo, |
Melanoma, |
NA |
|
|
|
- |
in-vitro, |
Melanoma, |
A431 |
|
|
|
*cl‑Casp8↑, *PARP↑, *P21↑, tumCV↓, TumCP↓, TumCCA↑, CycB/CCNB1↓, cycA1/CCNA1↓, CDK4↓, CDC2↓, P21↑, Apoptosis↑,
| - |
in-vitro, |
Melanoma, |
B16-F10 |
|
|
|
OS↑, DCells↑, T-Cell↑, Apoptosis↑, IL1↑, IFN-γ↓, IL10↑, TumCG↓, ROS↑, TumCP↓, TumCCA↑, ChrMod↑, CXCL9↓, CXCL12↓, CD4+↑, CD8+↑,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Melanoma, |
WM983B |
|
|
|
tumCV↓, ROS↑, antiOx↑, Apoptosis↑, BAX↑, P53↑, Casp3↑, Casp9↑,
| - |
vitro+vivo, |
Melanoma, |
A172 |
|
|
|
TumCG↓, TumCCA↑, Apoptosis↑, P21↑, CycB/CCNB1↓, cycA1/CCNA1↓, CDC2↓, CDC25↑, Bax:Bcl2↑, Casp9↑, ROS↑, JNK↑, ERK↑, eff↓,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
P53↑, Bcl-2↓, BAX↑, Cyt‑c↑, ERK↓, PKM2↓, Apoptosis↑, γH2AX↑, Casp3↑, cl‑PARP1↑,
| - |
in-vitro, |
Melanoma, |
MSTO-211H |
|
|
|
tumCV↓, Apoptosis↑, Sp1/3/4↓, p27↓, P21↓, cycD1/CCND1↓, Mcl-1↓, survivin↓,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
tumCV↓, selectivity↑, ROS↑, MMP↓, Apoptosis↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
Apoptosis↑, TumAuto↑, TumCP↓, TumCCA↑, P21↑, cycD1/CCND1↓, ER Stress↑, p‑eIF2α↑, CHOP↑, cl‑Casp3↑, p38↑, LC3B-II↑, Beclin-1↑, ROS↑, eff↓,
| - |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
IGF-1↓, Apoptosis↑, TumCCA↑, MMP↓, Casp3↑, P53↑, BAX↑, Mcl-1↓, EGFR↓, Src↑, KDR/FLK-1↓, p‑IGF-1↓, PI3K↓, Akt↓,
| - |
in-vitro, |
Melanoma, |
A431 |
|
|
|
ROS↑, Apoptosis↑, P53↑, BAX↑, MDM2↓, Bcl-2↓, Bcl-xL↓, Casp9↑, Casp7↑, Casp3↑, STAT3↓, cycD1/CCND1↓, survivin↓, eff↓,
| - |
in-vitro, |
Melanoma, |
SK-MEL-28 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
Apoptosis↑, JAK2↓, STAT3↓, cycD1/CCND1↓, survivin↓, ROS↑, eff↓,
| - |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
β-catenin/ZEB1↓, TCF↓, cMyc↓, cycD1/CCND1↓, TumCP↓, TumCCA↑, Apoptosis↑, cl‑Casp3↑, cl‑PARP↑, Casp7↑,
TumCG↓, Apoptosis↑, Casp3↑, ROS↑, p‑MAPK↑,
Showing Research Papers: 1 to 36 of 36
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 36
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GCLM↓, 1, GSH↓, 3, GSTA1↓, 1, GSTs↓, 1, HK1↓, 1, HO-1↑, 1, ICD↑, 1, MDA↑, 2, p66Shc↑, 1, ROS↑, 23, SOD↓, 1, SOD2↓, 1, TrxR↓, 1,
Metal & Cofactor Biology ⓘ
FTH1↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 2, CDC2↓, 2, CDC25↑, 1, MMP↓, 6, MPT↓, 1, MPT↑, 1, mtDam↑, 2, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
ALDOA↓, 1, cMyc↓, 1, ENO1↓, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1, NADPH↓, 1, PGK1↓, 1, PI3K/Akt↓, 1, PKM2↓, 1, PPP↓, 1, SIRT1↓, 1,
Cell Death ⓘ
Akt↓, 3, Akt↑, 1, Apoptosis↑, 36, BAX↑, 6, Bax:Bcl2↑, 2, Bcl-2↓, 6, Bcl-xL↓, 1, Casp3↑, 12, cl‑Casp3↑, 4, Casp7↑, 2, Casp8↑, 1, Casp9↑, 7, cl‑Casp9↑, 1, Cyt‑c↑, 4, JNK↑, 1, p‑MAPK↑, 1, Mcl-1↓, 3, MDM2↓, 1, Necroptosis↑, 1, necrosis↑, 1, p27↓, 1, p38↑, 1, Set9↑, 1, survivin↓, 4,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
ChrMod↑, 1, miR-21↓, 1, other↑, 1, tumCV↓, 10,
Protein Folding & ER Stress ⓘ
CHOP↑, 2, p‑eIF2α↑, 1, ER Stress↑, 3, HSP90↓, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, LC3B-II↑, 1, LC3s↑, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 3, P53↑, 5, p‑P53↑, 1, cl‑PARP↑, 4, cl‑PARP1↑, 2, γH2AX↑, 2,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, cycA1/CCNA1↓, 2, CycB/CCNB1↓, 2, cycD1/CCND1↓, 6, P21↓, 1, P21↑, 3, TumCCA↑, 12,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, ERK↑, 2, IGF-1↓, 1, p‑IGF-1↓, 1, PI3K↓, 1, PTEN↑, 1, PTPN6↑, 1, Src↓, 1, Src↑, 1, STAT1↓, 1, STAT3↓, 4, TCF↓, 1, TumCG↓, 9,
Migration ⓘ
CXCL12↓, 1, Ki-67↓, 1, TumCP↓, 9, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, EPR↑, 1, KDR/FLK-1↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, COX2↓, 1, CXCL9↓, 1, DCells↑, 1, HMGB1↑, 1, IFN-γ↓, 1, IL1↑, 1, IL10↑, 1, IL6↓, 1, Inflam↓, 1, JAK2↓, 2, NF-kB↓, 4, PD-L1↓, 1, T-Cell↑, 2,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 2, Dose↝, 2, eff↓, 8, eff↑, 3, eff↝, 1, RadioS↑, 2, selectivity↑, 5,
Clinical Biomarkers ⓘ
EGFR↓, 1, IL6↓, 1, Ki-67↓, 1, PD-L1↓, 1,
Functional Outcomes ⓘ
chemoPv↑, 1, OS↑, 1, toxicity↝, 1, TumVol↓, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 138
Pathway results for Effect on Normal Cells:
Cell Death ⓘ
cl‑Casp8↑, 1,
DNA Damage & Repair ⓘ
PARP↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 1,
Total Targets: 3
Scientific Paper Hit Count for: Apoptosis, Apoptosis
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:39 Cells:% prod#:% Target#:14 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page